Continuous versus interrupted suture technique for hepaticojejunostomy (HEKTIK trial)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00024395

Enrollment

200

Registered

2021-02-03

Start date

2020-03-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C25.0 C24

Interventions

Group 1: Interrupted suture technique for hepaticojejunostomy Group 2: Continuous suture technique for hepaticojejunostomy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Age = 18 years • Indication for the elective performance of a hepaticojejunostomy • Diameter of the common bile duct to be anastomosed = 5 mm (preoperative measurement in the imaging (CT or MRT)) • ASA I-III

Exclusion criteria

Exclusion criteria: • Performance of a hepaticojejunostomy as part of a liver resection or a liver transplantation • Simultaneous arterial reconstruction

Design outcomes

Primary

Measure	Time frame
Prevalence of early postoperative anastomotic leakage	—

Secondary

Measure	Time frame
- Operative time - Postoperative increase in cholestasis parameters (?GT, AP, bilirubin) - re-operation rate - re-intervention rate (ERCP, PTCD) - Morbidity (within the hospital stay and after 3 months) - Mortality (within the hospital stay and after 3 months) - Time for the Performance of the hepaticojejunostomy - Material costs for the hepaticojejunostomy	—

Countries

Germany

Contacts

Public ContactMaximilian Brunner

Chirurgische Klinik Universitätsklinikum Erlangen

Maximilian.brunner@uk-erlangen.de091318533296

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 17, 2026